News
-
-
PRESS RELEASE
Verbio SE: Positive momentum for biofuels: Regulatory developments in the EU and the US
Verbio SE closely monitors positive regulatory developments for biofuels in the EU and US, emphasizing the importance of a robust regulatory framework for climate-friendly fuels such as ethanol and biomethane -
PRESS RELEASE
EQS-Adhoc: Basler AG financial figures for the first six months of 2025: Positive business development in a continuing subdued market environment; company raises forecast for 2025
Basler AG reports positive financial results for the first half of 2025, with sales up by 20% and EBITDA over 100%. The company raises its forecast for 2025 amidst a challenging market environment -
PRESS RELEASE
EQS-Adhoc: Verbio SE: Preliminary EBITDA for the 2024/2025 financial year below forecast; non-cash impairments in the 2024/2025 consolidated financial statements
Verbio SE reports preliminary EBITDA for 2024/2025 financial year below forecast with non-cash impairments in consolidated financial statements -
-
PRESS RELEASE
NioCorp Can Make America the "Saudi Arabia of Scandium," CEO Mark Smith Tells Fox Business' Maria Bartiromo
Chairman and CEO of NioCorp Developments Ltd., Mark Smith, praises President Trump's critical minerals policies and discusses the potential of America becoming a scandium superpower with the Elk Creek Critical Minerals Project -
PRESS RELEASE
freenet exceeds expectations for free cash flow – customer base and service revenues continue to grow, guidance for adjusted EBITDA and free cash flow confirmed
freenet AG exceeds free cash flow expectations, confirms guidance for adjusted EBITDA and free cash flow, with customer base and service revenues growing -
-
-
PRESS RELEASE
Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC
Oxurion NV receives transparency notifications regarding changes in shareholding from Atlas Special Opportunities II, LLC as per Belgian Transparency legislation. Company combines therapeutic innovation with technology for new treatments